Journal: PLOS Biology
Article Title: RIN1 regulates developmental and pain-related plasticity in spinal synapses via NMDA receptor subunit trafficking
doi: 10.1371/journal.pbio.3003516
Figure Lengend Snippet: (A) Representative NMDAR-EPSCs and AMPAR-EPSCs recorded from P7 to P28. (B and C) Comparisons of NMDAR/AMPAR ratios (B) and decay kinetics of NMDAR-EPSCs (C) recorded from male and female mice. *P = 0.035, **P = 0.005, ## P = 0.002 (Mann-Whitney U test). n = 6 neurons (B) and 6-10 neurons (C) from 4-5 mice per group. (D) Changes of NMDAR-EPSCs recorded in spinal slices prepared from control and cKO-RIN1 mice at P5-P7 after bath perfusion of ifenprodil ( left ; F(31, 310) = 0.997, P = 0.475, repeated measurement, n = 6 neurons/group from 3-4 mice) or TCN-201 ( right ; F(31, 310) = 0.491, P = 0.991, repeated measurement, n = 6 neurons/group from 3-4 mice). (E) Changes of NMDAR-EPSCs recorded in control and cKO-RIN1 mice at P28-P35 after bath perfusion of ifenprodil ( left ; F(31, 310) = 7.877, P < 0.001, repeated measurement) or TCN-201 ( right ; F(31, 310) = 6.514, P < 0.001, repeated measurement). *P < 0.05 (post hoc Bonferroni test). n = 6 neurons/group from 3-4 mice. (F) Scheme for the injection of an adenoviral vector carrying RIN1 and/or EGFP in spinal cord dorsal horn of SOM-tdTomato mice at P5-P7 and electrophysiological recordings after 3-5 days. (G and H) Effects of RIN1 expression on the decay kinetics of NMDAR-EPSCs (G) and ifenprodil sensitivity (H) . **P = 0.004, ***P < 0.001 (Mann-Whitney U test). n = 15 neurons/group (G) and 6 neurons/group (H) from 4-5 mice. (I) Effect of ifenprodil on NMDAR-EPSCs recorded on SOM + interneurons expressing RIN1 or EGFP at P28-P35. n = 6 neurons from 2–3 mice/group. The data underlying this Figure can be found in .
Article Snippet: Primary antibodies used in this study included the mouse anti-RIN1 antibody (1:200; #H00009610-B01P, Novus Biologicals, Littleton, CO), rabbit anti-RIN1 antibody (1:200; #bs-6094R, Biosynthesis Biotechnology, Beijing, China), and mouse anti-PSD-95 antibody (1:200; #51-6900, Invitrogen).
Techniques: MANN-WHITNEY, Control, Injection, Plasmid Preparation, Expressing